{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:02:28Z","timestamp":1761930148547,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Human papillomavirus (HPV) is a common sexually transmitted pathogen and the cause of several cancers and of anogenital warts. With this study, we estimated the trend of hospitalizations for anogenital warts (AGWs) in the Veneto region (Italy) from 2007 to 2018.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The analysis included all the hospital discharge records of public and accredited private hospitals occurred in Veneto residents in the timespan 2007\u20132018. The ICD9-CM code 078.11 considered were those associated with condyloma acuminatum and those associated with surgical interventions for vulval\/vaginal warts, penile warts anal warts. Annual total and sex- and age-specific hospitalization rates and trends were calculated and correlated with the different HPV vaccine coverage over the study period.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We observed an overall reduction of hospitalization rates for AGWs: from 15.0 hospitalizations every 100,000 Veneto residents in years 2007\u201308 to 10.9 hospitalizations every 100,000 Veneto residents in year 2017\u201318 (\u2212\u200937.4%; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Reduction has been caused by a drop in hospitalizations in females - from a rate of 20.4\/100,000 in 2007\u20132008 to a rate of 10.8\/100,000 in 2017\u201318 (AAPC: -7.1; 95%CI: \u2212\u200910.6;-3.4); while in males, we observed a slight - but not statistically significant - increase in hospitalization rates.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The marked decline in hospitalization rates for AGWs in Veneto Region is probably attributable to the high coverage rates of HPV vaccination programs implemented since 2008.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05591-6","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T06:03:32Z","timestamp":1605679412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007\u20132018)"],"prefix":"10.1186","volume":"20","author":[{"given":"S.","family":"Cocchio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Prandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Furlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bertoncello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fonzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Saia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Baldovin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-9453","authenticated-orcid":false,"given":"V.","family":"Baldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"issue":"2","key":"5591_CR1","first-page":"80","volume":"40","author":"P Brianti","year":"2017","unstructured":"Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol. 2017;40(2):80\u20135.","journal-title":"New Microbiol"},{"issue":"5","key":"5591_CR2","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/jama.2018.20181","volume":"321","author":"D Grennan","year":"2019","unstructured":"Grennan D. Genital warts. JAMA. 2019;321(5):520.","journal-title":"JAMA."},{"key":"5591_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/DDDT.S91018","volume":"11","author":"PL Lopalco","year":"2016","unstructured":"Lopalco PL. Spotlight on the 9-valent HPV vaccine. Drug Des Devel Ther. 2016;11:35\u201344.","journal-title":"Drug Des Devel Ther"},{"key":"5591_CR4","unstructured":"Consiglio Superiore di Sanit\u00e0, Sessione XLVI, Sessioni congiunte II e III, seduta dell\u2019 11 gennaio 2007, http:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_600_allegato.pdf. Accessed 08 Oct 2020."},{"issue":"5","key":"5591_CR5","doi-asserted-by":"publisher","first-page":"e12905","DOI":"10.1111\/ecc.12905","volume":"27","author":"MG Cappelli","year":"2018","unstructured":"Cappelli MG, Fortunato F, Tafuri S, Boccalini S, Bonanni P, Prato R, Martinelli D. Cervical cancer prevention: an Italian scenario between organised screening and human papillomaviruses vaccination. Eur J Cancer Care (Engl). 2018;27(5):e12905.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"5591_CR6","unstructured":"Giambi C, Declich S, Finarelli AS, Pascucci MG, Salmaso S. e il Gruppo di Sanit\u00e0 Pubblica del Coordinamento Interregionale della Prevenzione. Strategie vaccinali nazionali e regionali per la vaccinazione anti-HPV e primi dati di copertura vaccinale: a che punto siamo. Epicentro. https:\/\/www.epicentro.iss.it\/ben\/2010\/novembre\/2. Accessed 08 Oct 2020."},{"key":"5591_CR7","first-page":"5","volume":"6","author":"C Favaretti","year":"2017","unstructured":"Favaretti C, de Waure C, Poscia A, Sacchini D, De Vincenzo R, Bechini A, Boccalini S, Bonanni P, Zanella B, Conversano M, Battista T, Giorgino A, Russo C, Ferro A, Mennini FS, Marcellusi A, Baio G, Nardi S, Squillace A. Il vaccino anti-HPV 9-valente: report di Health. Technol Assess (HTA) QIJPH. 2017;6:5.","journal-title":"Technol Assess (HTA) QIJPH"},{"key":"5591_CR8","unstructured":"DECRETO N. 89 del 17.05.2017, https:\/\/bandi.regione.veneto.it\/Public\/Download?idAllegato=5685. Accessed 08 Oct 2020."},{"issue":"1","key":"5591_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/003335491112600114","volume":"126","author":"TK Boehmer","year":"2011","unstructured":"Boehmer TK, Patnaik JL, Burnite SJ, Ghosh TS, Gershman K, Vogt RL. Use of hospital discharge data to evaluate notifiable disease reporting to Colorado's electronic disease reporting system. Public Health Rep. 2011;126(1):100\u20136.","journal-title":"Public Health Rep"},{"issue":"2","key":"5591_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/sti.2008.030999","volume":"85","author":"F Marra","year":"2009","unstructured":"Marra F, Ogilvie G, Colley L, Kliewer E, Marra CA. Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect. 2009;85(2):111\u20135.","journal-title":"Sex Transm Infect"},{"key":"5591_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1471-2334-8-76","volume":"8","author":"P Hillemanns","year":"2008","unstructured":"Hillemanns P, Breugelmans JG, Gieseking F, B\u00e9nard S, Lamure E, Littlewood KJ, Petry KU. Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. BMC Infect Dis. 2008;8:76.","journal-title":"BMC Infect Dis"},{"key":"5591_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1471-2334-13-140","volume":"13","author":"H Ali","year":"2013","unstructured":"Ali H, Guy RJ, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Donovan B. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis. 2013;13:140.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"5591_CR13","first-page":"5","volume":"12","author":"N Scheinfeld","year":"2006","unstructured":"Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J. 2006;12(3):5.","journal-title":"Dermatol Online J"},{"issue":"1","key":"5591_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12325-015-0178-4","volume":"32","author":"L Mariani","year":"2015","unstructured":"Mariani L, Vici P, Suligoi B, Checcucci-Lisi G, Drury R. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review. Adv Ther. 2015;32(1):10\u201330.","journal-title":"Adv Ther"},{"issue":"3","key":"5591_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"issue":"7","key":"5591_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/01.olq.0000245960.52668.e5","volume":"34","author":"F Jin","year":"2007","unstructured":"Jin F, Prestage G, Kippax SC, Pell CM, Donovan B. T DJ, Kaldor J, Grulich AE. Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study. Sex Transm Dis. 2007;34(7):488\u201393.","journal-title":"Sex Transm Dis"},{"key":"5591_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12879-018-2954-7","volume":"18","author":"S Cocchio","year":"2018","unstructured":"Cocchio S, Bertoncello C, Baldovin T, Buja A, Majori S, Baldo V. Self-reported genital warts among sexually active university students: a cross-sectional study. BMC Infect Dis. 2018;18:41.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5591_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12879-017-2361-5","volume":"17","author":"S Cocchio","year":"2017","unstructured":"Cocchio S, Baldovin T, Bertoncello C, Buja A, Furlan P, Saia M, Baldo V. Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: an observational study. BMC Infect Dis. 2017;17(1):249.","journal-title":"BMC Infect Dis"},{"key":"5591_CR19","unstructured":"Coperture vaccinali al 31\/12\/2017 per HPV (Aggiornamento 2 luglio 2018), http:\/\/www.salute.gov.it\/imgs\/C_17_tavole_27_allegati_iitemAllegati_0_fileAllegati_itemFile_1_file.pdf. Accessed 08 Oct 2020."},{"issue":"10197","key":"5591_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","volume":"394","author":"M Drolet","year":"2019","unstructured":"Drolet M, B\u00e9nard \u00c9, P\u00e9rez N, Brisson M. HPV vaccination impact study group. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497\u2013509.","journal-title":"Lancet."},{"issue":"n7\/8","key":"5591_CR21","first-page":"1","volume":"33","author":"MC Salfa","year":"2020","unstructured":"Salfa MC, Ferri M, Suligoi B e la Rete Sentinella dei Centri clinici e dei Laboratori di microbiologia clinica per le Infezioni Sessualmente Trasmesse. Le Infezioni Sessualmente Trasmesse: aggiornamento dei dati dei due Sistemi di sorveglianza sentinella attivi in Italia al 31 dicembre 2018. Not Ist Sup Sanit. 2020;33(n7\/8):1\u201339 https:\/\/wwwepicentroissit\/ist\/pdf\/notiziario-dati-2018pdf Accessed 08 Oct 2020.","journal-title":"Not Ist Sup Sanit"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05591-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05591-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05591-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T06:05:26Z","timestamp":1605679526000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05591-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5591"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05591-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"6 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data were treated with full confidentiality in accordance with Italian legislation. Before the database was made available to the authors, patient identifiers were replaced with anonymous codes that make it impossible to identify the individuals concerned. It was unnecessary to obtain patients\u2019 informed consent, given the anonymous nature of the data and its mandatory recording (anonymized data may be analyzed and used in aggregate form for scientific studies without further administrative authorization); therefore according to national guidelines (DM 18\/03\/1998) formal ethics approval was not needed. This study complies with the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Gian Marco Prandi is a PhD student at University of Padua funded by his employer MSD. No funding for the article was provided by MSD. All the other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"857"}}